GNI Group Ltd
F:3G6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
GNI Group Ltd
F:3G6
|
JP |
|
T
|
Tabcorp Holdings Ltd
OTC:TABCF
|
AU |
|
P
|
Pan Entertainment Co Ltd
KOSDAQ:068050
|
KR |
|
Highlight Event and Entertainment AG
SIX:HLEE
|
CH |
|
P
|
Porvair PLC
OTC:PVARF
|
UK |
|
UniCredit SpA
F:CRIP
|
IT |
|
Aegon NV
AEX:AGN
|
NL |
|
L
|
Lime Technologies AB (publ)
F:LTX
|
SE |
|
Z
|
Zhejiang Expressway Co Ltd
F:ZHJ
|
CN |
|
Aegon NV
OTC:AEGOF
|
NL |
|
C
|
CyberAgent Inc
F:CL2
|
JP |
Intrinsic Value
Is 3G6 undervalued or overvalued?
See the intrinsic value estimate for 
GNI Group Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
3G6 looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with 3G6’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What GNI Group Does
GNI Group Ltd is a Japanese biopharmaceutical company that discovers and develops new medicines, with a focus on hard-to-treat diseases such as fibrosis. Its work is centered on drug candidates rather than large-scale drug manufacturing, so the company acts mainly as a developer of potential therapies that can move through testing and, if successful, be licensed or commercialized with partners.
- Headquarters
- Japan JP
- Employees
- 990
- IPO date
- Aug 31, 2007
Revenue & Expenses Breakdown
GNI Group Ltd
Earnings Waterfall
GNI Group Ltd
The intrinsic value for GNI Group Ltd (3G6) under the Base Case is hidden EUR.
Compared with the current market price of 15.8 EUR, the stock appears hidden.